TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,284,000 | -48.1% | 345,791 | -7.8% | 0.03% | -46.7% |
| Q4 2021 | $17,883,000 | -26.7% | 374,910 | +2.1% | 0.06% | -34.1% |
| Q3 2021 | $24,385,000 | +3.3% | 367,081 | +21.3% | 0.09% | +8.3% |
| Q2 2021 | $23,607,000 | +12.0% | 302,578 | +35.7% | 0.08% | -3.4% |
| Q1 2021 | $21,087,000 | -35.4% | 222,931 | -16.8% | 0.09% | -42.4% |
| Q4 2020 | $32,667,000 | +36.7% | 268,091 | -2.0% | 0.15% | +11.0% |
| Q3 2020 | $23,899,000 | +68.5% | 273,571 | +24.6% | 0.14% | +41.7% |
| Q2 2020 | $14,183,000 | – | 219,584 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |